CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Cytogen

For profitContributed to NME

Also known as: CYTOGEN | Cytogen Corporation | CytoGen, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Mar 1, 2003

First marketed drug

Dec 31, 1992

First NDA

Dec 31, 1992

Last known activity

Nov 30, 2021

Acquired by EUSA → Jazz Pharmaceuticals on Jan 1, 2008

Timeline

1980s

  1. Jan 1, 1980

    Cytogen— Founded

1990s

  1. Dec 31, 1992

    satumomab pendetide— NDA Organization

  2. Oct 28, 1996

    capromab pendetide— Marketing Organization

2000s

  1. Jul 11, 2000

    Advanced Magnetics— Acquired

  2. Jan 1, 2008

    EUSA— Acquired By

2010s

  1. Apr 26, 2012

    Jazz Pharmaceuticals— Now

Drugs by trial phase (9 distinct, 7 trials)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (7)

Details

Founded
Princeton, NJ, US Jan 1, 1980
First NDA
Dec 31, 1992
Last known activity
Nov 30, 2021

Designations held

  • Orphan drug

Notes

Acquired by Jazz Pharmaceuticals 26 Apr 2012